Mind, Brain, and Drug: An Introduction to PsychopharmacologyCovering the basic principles of psychopharmacology, this textbook presents psychopharmacology and drugs of abuse in a readily understood manner. With all of the latest research and a straightforward, engaging writing style, Hedges offers complete coverage of the field without being unnecessarily detailed--and, as a result, provides students with a thorough introduction to this increasingly important area. |
From inside the book
Results 1-3 of 43
Page 52
... Half - Life and Steady State Drug Half - Life . Drugs have a half - life ( t1 / 2 ) , defined as the time taken for the body via metabolism to eliminate one - half of the drug ( Benet et al . , 1990 ) . Thus , after one half - life of a ...
... Half - Life and Steady State Drug Half - Life . Drugs have a half - life ( t1 / 2 ) , defined as the time taken for the body via metabolism to eliminate one - half of the drug ( Benet et al . , 1990 ) . Thus , after one half - life of a ...
Page 53
... half - life of about four to sixteen days ( Emmanuel et al . , 1999 ) . Not only does half - life vary from drug to drug , but also from person to person , depending on the types and amounts of cytochrome P450 enzymes . For instance ...
... half - life of about four to sixteen days ( Emmanuel et al . , 1999 ) . Not only does half - life vary from drug to drug , but also from person to person , depending on the types and amounts of cytochrome P450 enzymes . For instance ...
Page 59
... Half - life is defined as the amount of time required for a reduction in 50 percent of the original drug concentration . Half - life varies widely from drug to drug . Half - life also can vary considerably from person to person , with ...
... Half - life is defined as the amount of time required for a reduction in 50 percent of the original drug concentration . Half - life varies widely from drug to drug . Half - life also can vary considerably from person to person , with ...
Common terms and phrases
abnormalities abuse acetylcholine action potential addition ADHD adverse effects agonist alcohol Alzheimer's disease American Journal amphetamines antagonism anticonvulsant antidepressants anxiety disorder appears associated atypical antipsychotics axons barbiturates behavioral benzodiazepines bipolar disorder blood body brain bupropion buspirone caffeine cannabinoid cell Clinical Psychiatry clozapine cocaine cognitive concentrations cortex cytochrome P450 dementia dopamine dose Drug-Drug Interactions efficacy enzymes example factors fluoxetine function GABA ginkgo glutamate half-life hippocampal hyperactivity disorder increased inhibit insomnia involved John's wort Journal of Clinical Journal of Psychiatry kava lithium major depression marijuana mechanism of action medications metabolism methadone methylphenidate mirtazapine modafinil monoamine oxidase mood stabilizers nervous system neurobiology neurons Neuroscience neurotransmitter nicotine norepinephrine occur opiate opioid pain panic disorder patients Pharmacokinetics Pharmacology presynaptic Psychopharmacology psychosis result role schizophrenia seizure serotonin side effects social phobia SSRIs stimulation supplement symptoms synapse syndrome TCAs therapeutic therapy tion toxicity treatment typical antipsychotics valerian valproic acid venlafaxine withdrawal